Credit Suisse in one analyst report said the Mayveret gains were predominantly at the cost of Merck - does this tally with the call / anyone else's notes? thanks
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.